Literature DB >> 7808828

Final height and its predictive factors after renal transplantation in childhood.

A C Hokken-Koelega1, M A van Zaal, W van Bergen, M A de Ridder, T Stijnen, E D Wolff, R C de Jong, R A Donckerwolcke, S M de Muinck Keizer-Schrama, S L Drop.   

Abstract

A retrospective study is reported assessing final height (FH) and its predictive factors in 52 patients (31 male, 21 female) who underwent renal transplantation (RTx) before the age of 15 y. They received prednisone daily or on alternate days as well as azathioprine. The study period covered 20 y. FH remained below the third height percentile [height standard deviation score for chronologic age (hSDSCA) < -1.88] for most of these patients (77% males, 71% females). Median (range) FH was 165.0 (143.0-176.8) cm in males and 153.0 (135.0-168.4) cm in females. Median difference between FH and target height was 15.0 and 15.4 cm for males and females, respectively. For both sexes, the median hSDSCA was already below -1.88 at the start of the first hemodialysis, after which it decreased significantly until the first RTx. After RTx, there was no significant improvement of hSDSCA. The predictive factors for FH were determined by evaluating various factors simultaneous in a multiple regression analysis. This analysis provided a regression equation for predicting FH. A higher hSDSCA at the time of the first RTx and alternate-day versus daily prednisone therapy both had a significantly positive influence on FH, whereas a longer duration of reduced GFR (< 50 mL/min/1.73 m2) had a significantly negative effect on FH. Other factors such as age or bone age at first RTx, primary renal disease, duration of initial dialysis, repeat RTx, and the cumulative dose of prednisone did not influence FH significantly. In conclusion, 71-77% of patients that received their first renal transplant before the age of 15 ended up with severely short adult stature. Optimization of the hSDSCA at first RTx appears very important. Long-term administration of prednisone on alternate days would then result in optimal FH, particularly if the GFR remains above 50 mL/min/1.73 m2.

Entities:  

Mesh:

Year:  1994        PMID: 7808828     DOI: 10.1203/00006450-199409000-00009

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  17 in total

Review 1.  Growth hormone improves growth in pediatric renal transplant recipients--a systemic review and meta-analysis of randomized controlled trials.

Authors:  Yang Wu; Wei Cheng; Xiao-Dong Yang; Bo Xiang
Journal:  Pediatr Nephrol       Date:  2012-06-04       Impact factor: 3.714

2.  Growth in children on renal replacement therapy: a shrinking problem?

Authors:  Erum A Hartung; Susan L Furth
Journal:  Pediatr Nephrol       Date:  2013-06-23       Impact factor: 3.714

3.  Adult height in patients with advanced CKD requiring renal replacement therapy during childhood.

Authors:  Jérôme Harambat; Marjolein Bonthuis; Karlijn J van Stralen; Gema Ariceta; Nina Battelino; Anna Bjerre; Timo Jahnukainen; Valérie Leroy; György Reusz; Ana R Sandes; Manish D Sinha; Jaap W Groothoff; Christian Combe; Kitty J Jager; Enrico Verrina; Franz Schaefer
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

4.  Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement.

Authors:  John D Mahan; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2006-05-30       Impact factor: 3.714

5.  Body proportions before and during growth hormone therapy in children with chronic renal failure.

Authors:  Laura C G de Graaff; Paul G H Mulder; Anita C S Hokken-Koelega
Journal:  Pediatr Nephrol       Date:  2003-05-07       Impact factor: 3.714

6.  Glucocorticoid pharmacokinetics and growth retardation in children with renal transplants.

Authors:  Claire Chavatte; Geneviève Guest; Virginie Proust; Christine Le Bihan; François Gimenez; Anne Maisin; Chantal Loirat; Agnès Mogenet; Jean-Louis Bresson; Régis Hankard; Michel Broyer; Patrick Niaudet; Eric Singlas
Journal:  Pediatr Nephrol       Date:  2004-06-03       Impact factor: 3.714

7.  Anemia in pediatric renal transplant recipients.

Authors:  Joshua Yehuda Kausman; Harley Robert Powell; Colin Lindsay Jones
Journal:  Pediatr Nephrol       Date:  2004-03-09       Impact factor: 3.714

Review 8.  Current advances in chronic kidney disease in children: growth, cardiovascular, and neurocognitive risk factors.

Authors:  Larry A Greenbaum; Bradley A Warady; Susan L Furth
Journal:  Semin Nephrol       Date:  2009-07       Impact factor: 5.299

9.  Growth and maturation improvement in children on renal replacement therapy over the past 20 years.

Authors:  Doris Franke; Stella Winkel; Jutta Gellermann; Uwe Querfeld; Lars Pape; Jochen H H Ehrich; Dieter Haffner; Leo Pavičić; Miroslav Zivičnjak
Journal:  Pediatr Nephrol       Date:  2013-05-25       Impact factor: 3.714

10.  Final adult height in kidney recipients who underwent highly successful transplantation as children: a single-center experience.

Authors:  Hiroshi Fujii; Hiroko Chikamoto; Yuko Akioka; Motoshi Hattori
Journal:  Clin Exp Nephrol       Date:  2013-07-18       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.